OPA-6566 Ophthalmic Solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OPA-6566 Ophthalmic Solution, covering 2014-03-11 to 2014-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]